Valiant Laboratories Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 66.08 | 55.35 | 46.83 |
| Operating Expense | 60.80 | 54.49 | 45.93 |
| Net Profit | 3.53 | 0.03 | 0.17 |
| Net Profit Margin | 5.34% | 0.05% | 0.36% |
| Earning Per Share | 0.65 | 0.01 | 0.03 |
| EBIDTA | 5.12 | 0.78 | 0.85 |
| Effective Tax Rate | 19.92% | 0% | 3.30% |
Particulars
Mar 2026
Revenue66.08
Operating Expense60.80
Net Profit3.53
Net Profit Margin5.34
Earning Per Share0.65
EBIDTA5.12
Effective Tax Rate19.92
